Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 20
1981 40
1982 55
1983 78
1984 80
1985 103
1986 129
1987 130
1988 106
1989 120
1990 90
1991 120
1992 97
1993 91
1994 88
1995 58
1996 61
1997 59
1998 70
1999 53
2000 53
2001 70
2002 51
2003 41
2004 32
2005 45
2006 37
2007 48
2008 52
2009 44
2010 43
2011 38
2012 38
2013 47
2014 31
2015 32
2016 31
2017 14
2018 32
2019 21
2020 27
2021 33
2022 21
2023 20
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

2,481 results

Results by year

Filters applied: . Clear all
Page 1
Eflornithine.
Jobanputra KS, Rajpal AV, Nagpur NG. Jobanputra KS, et al. Indian J Dermatol Venereol Leprol. 2007 Sep-Oct;73(5):365-6. doi: 10.4103/0378-6323.35752. Indian J Dermatol Venereol Leprol. 2007. PMID: 17921631 Review. No abstract available.
Topical eflornithine.
Balfour JA, McClellan K. Balfour JA, et al. Am J Clin Dermatol. 2001;2(3):197-201; discussion 202. doi: 10.2165/00128071-200102030-00009. Am J Clin Dermatol. 2001. PMID: 11705097 Review.
Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase which is thought to slow hair growth by inhibiting this enzyme in hair follicles. ...Only burning/stinging/tingling was markedly more common with eflornithine than with placebo.
Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase which is thought to slow hair growth by inhi
Hair Removal Practices: A Literature Review.
Kang CN, Shah M, Lynde C, Fleming P. Kang CN, et al. Skin Therapy Lett. 2021 Sep;26(5):6-11. Skin Therapy Lett. 2021. PMID: 34524781 Free article. Review.
Hair removal methods can be divided into two categories: 1) depilation, which involves removing the hair shaft and includes shaving and chemical depilatories, and 2) epilation, which involves removing the hair shaft, follicle, and bulb, and includes plucking, threading, waxing, s …
Hair removal methods can be divided into two categories: 1) depilation, which involves removing the hair shaft and includes shaving and chem …
Clinical importance of eflornithine (alpha-difluoromethylornithine) for the treatment of malignant gliomas.
Levin VA, Ictech SE, Hess KR. Levin VA, et al. CNS Oncol. 2018 Apr;7(2):CNS16. doi: 10.2217/cns-2017-0031. Epub 2018 Jan 30. CNS Oncol. 2018. PMID: 29378419 Free PMC article. Review.
This review covers the literature between 1989 and 2007 on studies relevant to the neuro-oncology usage of eflornithine (alpha-difluoromethylornithine), an oral agent that irreversibly inhibits the enzyme ornithine decarboxylase. It covers the use of eflornithine, a …
This review covers the literature between 1989 and 2007 on studies relevant to the neuro-oncology usage of eflornithine (alpha-difluo …
Enantiospecific antitrypanosomal in vitro activity of eflornithine.
Boberg M, Cal M, Kaiser M, Jansson-Löfmark R, Mäser P, Ashton M. Boberg M, et al. PLoS Negl Trop Dis. 2021 Jul 12;15(7):e0009583. doi: 10.1371/journal.pntd.0009583. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34252098 Free PMC article.
This parasitic disease, transmitted by the tsetse fly, is lethal unless treated. Eflornithine is administered by repeated intravenous infusions as a racemic mixture of L-eflornithine and D-eflornithine. ...Antitrypanosomal in vitro activity at varying drug co …
This parasitic disease, transmitted by the tsetse fly, is lethal unless treated. Eflornithine is administered by repeated intravenous …
Eflornithine for the treatment of human African trypanosomiasis.
Burri C, Brun R. Burri C, et al. Parasitol Res. 2003 Jun;90 Supp 1:S49-52. doi: 10.1007/s00436-002-0766-5. Epub 2002 Dec 10. Parasitol Res. 2003. PMID: 12811548 Review.
Eflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. ...Adverse drug reactions during eflornithine therapy are frequent and the characteristics are similar to other cytotoxic drugs for the treatm
Eflornithine is the only new molecule registered for the treatment of human African trypanosomiasis over the last 50 years. ...Advers
Does eflornithine help women face hirsutism?
[No authors listed] [No authors listed] Drug Ther Bull. 2007 Aug;45(8):62-4. doi: 10.1136/dtb.2007.45862. Drug Ther Bull. 2007. PMID: 17718095 Review.
Many women develop male-pattern facial hair (facial hirsutism), which can be distressing and difficult to treat. Eflornithine (Vaniqa - Shire) is a topical cream available only on prescription for treating women with facial hirsutism. ...
Many women develop male-pattern facial hair (facial hirsutism), which can be distressing and difficult to treat. Eflornithine (Vaniqa …
Eflornithine.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2001 Dec 1;58(23):2244. doi: 10.1093/ajhp/58.23.2244. Am J Health Syst Pharm. 2001. PMID: 11763800 No abstract available.
Eflornithine. A new drug in the treatment of sleeping sickness.
Van Bogaert I, Haemers A. Van Bogaert I, et al. Pharm Weekbl Sci. 1989 Jun 23;11(3):69-75. doi: 10.1007/BF02110252. Pharm Weekbl Sci. 1989. PMID: 2505225 Review.
After a short description of trypanosomiasis and the current treatment, the mechanism of action of eflornithine is discussed, some clinical data is given and attention is paid to recently discovered analogues of eflornithine. Some examples of combination therapy wit …
After a short description of trypanosomiasis and the current treatment, the mechanism of action of eflornithine is discussed, some cl …
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Oesterheld J, Ferguson W, Kraveka JM, Bergendahl G, Clinch T, Lorenzi E, Berry D, Wada RK, Isakoff MS, Eslin DE, Brown VI, Roberts W, Zage P, Harrod VL, Mitchell DS, Hanson D, Saulnier Sholler GL. Oesterheld J, et al. J Clin Oncol. 2024 Jan 1;42(1):90-102. doi: 10.1200/JCO.22.02875. Epub 2023 Oct 26. J Clin Oncol. 2024. PMID: 37883734 Free PMC article. Clinical Trial.
PURPOSE: Long-term survival in high-risk neuroblastoma (HRNB) is approximately 50%, with mortality primarily driven by relapse. Eflornithine (DFMO) to reduce risk of relapse after completion of immunotherapy was investigated previously in a single-arm, phase II study (NMTR …
PURPOSE: Long-term survival in high-risk neuroblastoma (HRNB) is approximately 50%, with mortality primarily driven by relapse. Eflornith
2,481 results